Suppr超能文献

台湾地区大肠杆菌对氟喹诺酮类药物敏感性降低及耐药性的出现与不同选择压力的作用

Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures.

作者信息

McDonald L C, Chen F J, Lo H J, Yin H C, Lu P L, Huang C H, Chen P, Lauderdale T L, Ho M

机构信息

Division of Clinical Research, National Health Research Institutes, Taipei, Taiwan, Republic of China.

出版信息

Antimicrob Agents Chemother. 2001 Nov;45(11):3084-91. doi: 10.1128/AAC.45.11.3084-3091.2001.

Abstract

A survey of 1,203 Escherichia coli isolates from 44 hospitals in Taiwan revealed that 136 (11.3%) isolates were resistant to fluoroquinolones and that another 261 (21.7%) isolates had reduced susceptibility. Resistance was more common in isolates responsible for hospital-acquired (mostly in intensive care units) infections (17.5%) than in other adult inpatient (11.4%; P = 0.08) and outpatient isolates (11.9%; P > 0.1). Similarly, reduced susceptibility was more common in isolates responsible for hospital-acquired infections (30.9%) than in other adult inpatient (21.0%; P = 0.04) and outpatient (21.4%; P = 0.06) isolates. Isolates from pediatric patients were less likely to be resistant (1.3 versus 12.0%; P < 0.01) but were nearly as likely to have reduced susceptibility (17.7 versus 21.9%; P > 0.1) as nonpediatric isolates. There was an inverse relationship in the proportion of isolates that were resistant versus the proportion that had reduced susceptibility among isolates from individual hospitals (R = 0.031; P < 0.05). In an analysis of isolates from two hospitals, all 9 resistant strains possessed double point mutations in gyrA and all 19 strains with reduced susceptibility strains had single point mutations; no mutations were found among fully susceptible strains. Risk factors for resistance included underlying cancer (odds ratio [OR], 83; 95% confidence interval [CI(95)], 7.3 to 2,241; P < 0.001), exposure to a quinolone (OR, undefined; P = 0.02), and exposure to a nonquinolone antibiotic (OR, 20; CI(95), 2.2 to 482; P < 0.001); underlying cancer was the only independent risk factor (OR, 83; CI(95), 8.6 to 807; P < 0.001). There were no significant associations between any of these factors and reduced susceptibility. Whereas acute and chronic quinolone use in cancer patients is a major selective pressure for resistance, other undetermined but distinct selective pressures appear to be more responsible for reduced susceptibility to fluoroquinolones in E. coli.

摘要

一项针对台湾44家医院的1203株大肠杆菌分离株的调查显示,136株(11.3%)分离株对氟喹诺酮类耐药,另有261株(21.7%)分离株敏感性降低。耐药性在导致医院获得性感染(主要在重症监护病房)的分离株中(17.5%)比在其他成人住院患者(11.4%;P = 0.08)和门诊患者分离株中(11.9%;P > 0.1)更为常见。同样,敏感性降低在导致医院获得性感染的分离株中(30.9%)比在其他成人住院患者(21.0%;P = 0.04)和门诊患者(21.4%;P = 0.06)分离株中更为常见。儿科患者的分离株耐药可能性较小(1.3%对12.0%;P < 0.01),但敏感性降低的可能性与非儿科分离株相近(17.7%对21.9%;P > 0.1)。在各医院分离株中,耐药分离株比例与敏感性降低分离株比例呈负相关(R = 0.031;P < 0.05)。在对两家医院分离株的分析中,所有9株耐药菌株在gyrA中均有双点突变,所有19株敏感性降低菌株均有单点突变;在完全敏感菌株中未发现突变。耐药的危险因素包括潜在癌症(比值比[OR],83;95%置信区间[CI(95)],7.3至2241;P < 0.001)、接触喹诺酮类药物(OR,未定义;P = 0.02)以及接触非喹诺酮类抗生素(OR,20;CI(95),2.2至482;P < 0.001);潜在癌症是唯一的独立危险因素(OR,83;CI(95),8.6至807;P < 0.001)。这些因素与敏感性降低之间均无显著关联。虽然癌症患者急性和慢性使用喹诺酮类药物是耐药的主要选择压力,但其他未确定但不同的选择压力似乎对大肠杆菌对氟喹诺酮类药物敏感性降低更具责任。

相似文献

引用本文的文献

本文引用的文献

3
Treatment options for acute uncomplicated cystitis in adults.
J Antimicrob Chemother. 2000 Aug;46 Suppl A:23-27.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验